BayCare Central Pharmacy has voluntarily recalled 250 syringes of Iohexol (300 mg Iodine/mL), an injectable contrast agent used in medical imaging. The syringes were mislabeled as containing 300 mg of iodine per mL when they actually contained a higher strength of 350 mg per mL. This recall affects 8 mL syringes packaged in 5-count bags labeled under the brand name Omnipaque. No injuries or adverse incidents have been reported to date.
Using a higher concentration of iodine contrast than intended can lead to incorrect dosing during medical procedures, which may increase the risk of adverse reactions or complications for patients.
Compounded with GE Healthcare product; each mL contains 647 mg of iohexol; syringes mislabeled as 300 mg/mL contained 350 mg/mL.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.